Skip to Main Content

Rise and shine, everyone, another busy day is on the way. Our short person has left for the local schoolhouse for another day of learning and we are monitoring the progress of our official mascot, who has taken ill. To cope, yes, we are brewing cups of stimulation — cinnamon French vanilla is our choice today. Meanwhile, here are some tidbits. Hope you have a productive day and please do keep in touch.

Drug prices will rise an estimated 3.59% through next year, continuing a recent trend of moderate increases, although the high cost of some pharmaceuticals still rankles health systems and patients, according to Modern Healthcare, citing research by one group purchasing organization. Advocacy and awareness as well as a more competitive market have contributed to more modest price increases over recent years, according to Vizient’s outlook from July 2019 through June 2021.


The race is on to halt the coronavirus that is spreading across China and other countries, and for Richard Hatchett, head of the Coalition for Epidemic Preparedness Innovations, this is the first big test of Cepi’s mission to develop vaccines to combat future epidemics, The Financial Times writes. Cepi, set up three years ago with a $1 billion budget target, is a partnership of governments, industry, and charities. It has moved to select two biotechs and the University of Queensland in Australia to lead the vaccine hunt. A fourth partnership is imminent.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!